Thrombelastography (TEG) has been used to monitor the coagulation function of patients since it was first described in 1948 and has been repeatedly recommended in the guidelines.This article shows the reader the assay and its clinical application.This article focuses on evidence that supports the use of TEG in the emergen cy department.